These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 37243260)

  • 21. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
    Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
    Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioluminescent virion shells: new tools for quantitation of AAV vector dynamics in cells and live animals.
    Asokan A; Johnson JS; Li C; Samulski RJ
    Gene Ther; 2008 Dec; 15(24):1618-22. PubMed ID: 18668144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Robust and All-Inclusive Pipeline for Shuffling of Adeno-Associated Viruses.
    Herrmann AK; Bender C; Kienle E; Grosse S; El Andari J; Botta J; Schürmann N; Wiedtke E; Niopek D; Grimm D
    ACS Synth Biol; 2019 Jan; 8(1):194-206. PubMed ID: 30513195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders.
    Mak KY; Rajapaksha IG; Angus PW; Herath CB
    Curr Gene Ther; 2017; 17(1):4-16. PubMed ID: 28292253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.
    Lotfinia M; Abdollahpour-Alitappeh M; Hatami B; Zali MR; Karimipoor M
    Clin Exp Med; 2019 Aug; 19(3):289-298. PubMed ID: 31054018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-existing anti-adeno-associated virus antibodies as a challenge in AAV gene therapy.
    Louis Jeune V; Joergensen JA; Hajjar RJ; Weber T
    Hum Gene Ther Methods; 2013 Apr; 24(2):59-67. PubMed ID: 23442094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
    Grimm D; Kay MA; Kleinschmidt JA
    Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction.
    Hauck B; Zhao W; High K; Xiao W
    J Virol; 2004 Dec; 78(24):13678-86. PubMed ID: 15564477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic trafficking, endosomal escape, and perinuclear accumulation of adeno-associated virus type 2 particles are facilitated by microtubule network.
    Xiao PJ; Samulski RJ
    J Virol; 2012 Oct; 86(19):10462-73. PubMed ID: 22811523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor Switching in Newly Evolved Adeno-associated Viruses.
    Havlik LP; Das A; Mietzsch M; Oh DK; Ark J; McKenna R; Agbandje-McKenna M; Asokan A
    J Virol; 2021 Sep; 95(19):e0058721. PubMed ID: 34232726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.
    Bartlett JS; Wilcher R; Samulski RJ
    J Virol; 2000 Mar; 74(6):2777-85. PubMed ID: 10684294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
    Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
    J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery Vectors.
    Hajba L; Guttman A
    Curr Mol Med; 2020; 20(10):806-813. PubMed ID: 32748744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of Adeno-Associated Virus Serotypes.
    Rieser R; Penaud-Budloo M; Bouzelha M; Rossi A; Menzen T; Biel M; Büning H; Ayuso E; Winter G; Michalakis S
    J Pharm Sci; 2020 Jan; 109(1):854-862. PubMed ID: 31639391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-Associated Virus Genome Interactions Important for Vector Production and Transduction.
    Maurer AC; Weitzman MD
    Hum Gene Ther; 2020 May; 31(9-10):499-511. PubMed ID: 32303138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
    Wagner HJ; Weber W; Fussenegger M
    Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.
    Fakhiri J; Grimm D
    Mol Ther; 2021 Dec; 29(12):3359-3382. PubMed ID: 33831556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide RNAi screening identifies host restriction factors critical for in vivo AAV transduction.
    Mano M; Ippodrino R; Zentilin L; Zacchigna S; Giacca M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11276-81. PubMed ID: 26305933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.